The Cooper Companies, Inc. $COO Stock Position Lifted by JANA Partners Management LP

JANA Partners Management LP increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,565,158 shares of the medical device company’s stock after acquiring an additional 45,538 shares during the quarter. Cooper Companies comprises 15.3% of JANA Partners Management LP’s holdings, making the stock its 2nd biggest position. JANA Partners Management LP’s holdings in Cooper Companies were worth $254,909,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Wellington Management Group LLP boosted its stake in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after acquiring an additional 4,756,178 shares in the last quarter. Generation Investment Management LLP acquired a new position in shares of Cooper Companies during the fourth quarter worth $233,539,000. Diamond Hill Capital Management Inc. increased its position in shares of Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after purchasing an additional 2,720,594 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. Finally, Franklin Resources Inc. lifted its holdings in shares of Cooper Companies by 108.2% during the 4th quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after purchasing an additional 2,089,763 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

COO has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. lowered their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a report on Wednesday, May 27th. Finally, Mizuho set a $85.00 price target on Cooper Companies and gave the stock an “outperform” rating in a research note on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $81.36.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $72.32 on Monday. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The stock has a market cap of $14.10 billion, a price-to-earnings ratio of 61.29, a PEG ratio of 1.89 and a beta of 0.84. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The business has a 50-day moving average price of $68.36 and a 200-day moving average price of $71.71.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.